Preparation and Evaluation of a Combined Inactivated Vaccine Against Corynebacterium pseudotuberculosis, Trueperella pyogenes, and Staphylococcus aureus

Background: Caseous lymphadenitis (CLA) is a significant infectious disease in sheep and goats, traditionally associated with Corynebacterium pseudotuberculosis. However, recent evidence highlights the polymicrobial nature of CLA, with Trueperella pyogenes and Staphylococcus aureus frequently co-isolated from lesions. Current vaccines mainly target single pathogens, and combined inactivated vaccines against all three bacteria are lacking. Methods: We developed a trivalent inactivated vaccine using strains CpS1, TpS1, and SaS9, inactivated with 0.2% formalin and formulated with either PBS, Freund’s adjuvant, or aluminum hydroxide adjuvant. Vaccine quality, safety, and immunogenicity were evaluated in experimental goats. The aluminum hydroxide-adjuvanted vaccine was further assessed for protective efficacy via challenge with individual pathogens and in field trials on goat and sheep farms. Results: All formulations induced specific antibodies against the three pathogens, with Freund’s adjuvant eliciting the highest level, while aluminum hydroxide provided a favorable safety profile and induced antibody levels that were numerically lower than but not statistically distinguishable from the Freund’s adjuvant group at most time points; however, the small group size (n = 6) limited the statistical power to detect differences between adjuvants. The aluminum hydroxide-adjuvanted vaccine conferred protection rates of 66.7% against C. pseudotuberculosis, 83.3% against T. pyogenes, and 83.3% against S. aureus in challenge trials. In field studies, vaccination was associated with a lower observed incidence of CLA, from 12.5% in unvaccinated controls to 2.5% in vaccinated goats and from 8% to 2% in vaccinated sheep within 90 days post-immunization. Conclusions: The trivalent inactivated vaccine with aluminum hydroxide adjuvant showed promising immunogenicity and preliminary protective efficacy against experimental challenge and was associated with a lower observed overall abscess incidence under the investigated field conditions.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2026-10-26
DOI
https://doi.org/10.3390/vaccines14110930
Primary Topic
Diphtheria, Corynebacterium, and Tetanus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preparation and Evaluation of a Combined Inactivated Vaccine Against Corynebacterium pseudotuberculosis, Trueperella pyogenes, and Staphylococcus aureus

Xindong Bai, Bin Wang, Xinxin Qiu, Yanqing Jia et al.
Vaccines
Diphtheria, Corynebacterium, and Tetanus
article

Preparation and Evaluation of a Combined Inactivated Vaccine Against Corynebacterium pseudotuberculosis, Trueperella pyogenes, and Staphylococcus aureus

Xindong Bai, Bin Wang, Xinxin Qiu, Yanqing Jia, Yuchen Wei, Zengqi Yang
article en

Abstract

Background: Caseous lymphadenitis (CLA) is a significant infectious disease in sheep and goats, traditionally associated with Corynebacterium pseudotuberculosis. However, recent evidence highlights the polymicrobial nature of CLA, with Trueperella pyogenes and Staphylococcus aureus frequently co-isolated from lesions. Current vaccines mainly target single pathogens, and combined inactivated vaccines against all three bacteria are lacking. Methods: We developed a trivalent inactivated vaccine using strains CpS1, TpS1, and SaS9, inactivated with 0.2% formalin and formulated with either PBS, Freund’s adjuvant, or aluminum hydroxide adjuvant. Vaccine quality, safety, and immunogenicity were evaluated in experimental goats. The aluminum hydroxide-adjuvanted vaccine was further assessed for protective efficacy via challenge with individual pathogens and in field trials on goat and sheep farms. Results: All formulations induced specific antibodies against the three pathogens, with Freund’s adjuvant eliciting the highest level, while aluminum hydroxide provided a favorable safety profile and induced antibody levels that were numerically lower than but not statistically distinguishable from the Freund’s adjuvant group at most time points; however, the small group size (n = 6) limited the statistical power to detect differences between adjuvants. The aluminum hydroxide-adjuvanted vaccine conferred protection rates of 66.7% against C. pseudotuberculosis, 83.3% against T. pyogenes, and 83.3% against S. aureus in challenge trials. In field studies, vaccination was associated with a lower observed incidence of CLA, from 12.5% in unvaccinated controls to 2.5% in vaccinated goats and from 8% to 2% in vaccinated sheep within 90 days post-immunization. Conclusions: The trivalent inactivated vaccine with aluminum hydroxide adjuvant showed promising immunogenicity and preliminary protective efficacy against experimental challenge and was associated with a lower observed overall abscess incidence under the investigated field conditions.

VaccinesVol. 14(11)
Innovation Team (China) (HK), Shaanxi A&F Technology University (CN), Northwest A&F University (CN)
Openalex Percentile: Top 15%
Diphtheria, Corynebacterium, and Tetanus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon